Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
21.81
+0.14 (0.65%)
At close: May 12, 2025, 4:00 PM
21.81
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Claritev Market Cap
Claritev has a market cap or net worth of $364.79 million as of May 12, 2025. Its market cap has decreased by -4.38% in one year.
Market Cap
364.79M
Enterprise Value
4.97B
1-Year Change
-4.38%
Ranking
Category
Stock Price
$21.81
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $364.79M, an increase of 50.12%. That is a compound annual growth rate of 8.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 362.45M | 51.65% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |